Futura Medical plc (FAMDF)

USD 0.38

(0.0%)

Market Cap (In USD)

115.4 Million

Revenue (In USD)

3.1 Million

Net Income (In USD)

-6.51 Million

Avg. Volume

9223.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.28-0.65
PE
-
EPS
-
Beta Value
1.265
ISIN
GB0033278473
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. James Henry Barder
Employee Count
-
Website
https://www.futuramedical.com
Ipo Date
2012-05-15
Details
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.